Department of Medicine, Division of Gastroenterology
Digestive System Diseases | Gastroenterology | Health Services Administration | Hepatology | Infectious Disease | Substance Abuse and Addiction | Virus Diseases
The Coronavirus Disease 2019 (COVID-19) pandemic has exacted a heavy toll on patients with alcohol-associated liver disease (ALD) and alcohol use disorder (AUD). The collective burden of ALD and AUD was large and growing, even before the COVID-19 pandemic. There is accumulating evidence that this pandemic has had a large direct effect on these patients and is likely to produce indirect effects through delays in care, psychological strain, and increased alcohol use. Now a year into the pandemic, it is important that clinicians fully understand the effects of the COVID-19 pandemic on patients with ALD and AUD. To fill existing gaps in knowledge, the scientific community must set research priorities for patients with ALD regarding their risk of COVID-19, prevention/treatment of COVID-19, changes in alcohol use during the pandemic, best use of AUD treatments in the COVID-19 era, and downstream effects of this pandemic on ALD.
Conclusion: The COVID-19 pandemic has already inflicted disproportionate harms on patients with ALD, and ongoing, focused research efforts will be critical to better understand the direct and collateral effects of this pandemic on ALD.
Coronavirus Disease 2019, COVID-19, pandemic, alcohol-associated liver disease, alcohol use disorder
Rights and Permissions
Copyright © 2021 The Authors. Hepatology Communications published by Wiley Periodicals LLC on behalf of American Association for the Study of Liver Diseases. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
DOI of Published Version
Moon AM, Curtis B, Mandrekar P, Singal AK, Verna EC, Fix OK. Alcohol-Associated Liver Disease Before and After COVID-19-An Overview and Call for Ongoing Investigation. Hepatol Commun. 2021 Sep;5(9):1616-1621. doi: 10.1002/hep4.1747. Epub 2021 Jun 5. PMID: 34510833; PMCID: PMC8239751. Link to article on publisher's site
Moon AM, Curtis B, Mandrekar P, Singal AK, Verna EC, Fix OK. (2021). Alcohol-Associated Liver Disease Before and After COVID-19 - An Overview and Call for Ongoing Investigation. COVID-19 Publications by UMass Chan Authors. https://doi.org/10.1002/hep4.1747. Retrieved from https://escholarship.umassmed.edu/covid19/261
Creative Commons License
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 4.0 License.
Digestive System Diseases Commons, Gastroenterology Commons, Health Services Administration Commons, Hepatology Commons, Infectious Disease Commons, Substance Abuse and Addiction Commons, Virus Diseases Commons